Michelle W Wong-Brown (Michelle Wong-Brown)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Histone Deacetylase

Candida Albicans

Pregnancy Outcomes

Top Venues

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Arunita Ghosh, Ken Jaaback, Angela Boulton, Michelle W Wong-Brown, Steve Raymond, Partha Dutta, Nikola A Bowden, Arnab Ghosh
Fusobacterium nucleatum : An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells 13 (8) (2024)
Arunita Ghosh, Ken Jaaback, Angela Boulton, Michelle W Wong-Brown, Steve Raymond, Partha Dutta, Nikola A Bowden, Arnab Ghosh
Fusobacterium nucleatum : An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells 13 (8) (2024)
Arunita Ghosh, Ken Jaaback, Angela Boulton, Michelle W Wong-Brown, Steve Raymond, Partha Dutta, Nikola A Bowden, Arnab Ghosh
Fusobacterium nucleatum : An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells 13 (8) (2024)
Arunita Ghosh, Ken Jaaback, Angela Boulton, Michelle W Wong-Brown, Steve Raymond, Partha Dutta, Nikola A Bowden, Arnab Ghosh
Fusobacterium nucleatum : An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells 13 (8) (2024)
Na Li, Belle W X Lim, Ella R Thompson, Simone McInerny, Magnus Zethoven, Dane Cheasley, Simone M Rowley, Michelle W Wong-Brown, Lisa Devereux, Kylie L Gorringe, Erica K Sloan, Alison Trainer, Rodney J Scott, Paul A James, Ian G Campbell
Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. NPJ breast cancer 7 (1) (2021)
Bayley G Matthews, Nikola A Bowden, Michelle W Wong-Brown
Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer. Cancers 13 (23) (2021)